“…In the last decade, healthcare systems have greatly evolved, they have integrated point of care (POC) diagnostics as an integral part of their transformation [93]. POC allows the clinician to perform laboratory tests near the patient with quicker results, instead of conducting the tests in a routine laboratory set away from the patient, thus contributing to better patient care [94]. Since, the conventional assays (Northern blot, microarray assay, in situ hybridization, RT-qPCR, and next generation gene sequencing) are far from achieving the POC in breast cancer, development of miRNAs POC diagnostic tools and assays is a promising field of research in the upcoming decade as it can maximize diagnostic, prognostic, and predictive benefits for the patient [95,96,97,98].…”